Institutional shares held 66.1 Million
4.83M calls
83.7K puts
Total value of holdings $245M
$17.9M calls
$309K puts
Market Cap $160M
43,269,200 Shares Out.
Institutional ownership 152.82%
# of Institutions 128


Latest Institutional Activity in LRMR

Top Purchases

Q2 2025
Millennium Management LLC Shares Held: 3.66M ($13.5M)
Q2 2025
Opaleye Management Inc. Shares Held: 4.11M ($15.2M)
Q2 2025
Citadel Advisors LLC Shares Held: 1.34M ($4.94M)
Q2 2025
Two Sigma Advisers, LP Shares Held: 1.15M ($4.24M)
Q2 2025
Caption Management, LLC Shares Held: 689K ($2.55M)

Top Sells

Q2 2025
Goldman Sachs Group Inc Shares Held: 132K ($487K)
Q2 2025
Renaissance Technologies LLC Shares Held: 562K ($2.08M)
Q2 2025
Morgan Stanley Shares Held: 169K ($625K)
Q2 2025
Sphera Funds Management Ltd. Shares Held: 197K ($728K)
Q2 2025
Vanguard Group Inc Shares Held: 2.14M ($7.93M)

About LRMR

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.


Insider Transactions at LRMR

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
9.55M Shares
From 5 Insiders
Open market or private purchase 9.38M shares
Grant, award, or other acquisition 172K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on LRMR

Follow Larimar Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LRMR shares.

Notify only if

Insider Trading

Get notified when an Larimar Therapeutics, Inc. insider buys or sells LRMR shares.

Notify only if

News

Receive news related to Larimar Therapeutics, Inc.

Track Activities on LRMR